Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed

Fanjie Jin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5087388886. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper · 2022: 1 paper

Papers 4

  1. ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis. Co-author DOI 10.1038/s41416-022-01927-y↗
  2. PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2021.05.021↗
  3. Proteasome inhibitor MG132 suppresses pancreatic ductal adenocarcinoma-cell migration by increasing ESE3 expression. Co-author DOI 10.3892/ol.2019.11157↗
  4. IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer. First author DOI 10.7150/thno.42416↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tiansuo Zhao · 4 shared papers, 2020–2022 · strength 0.51
  2. Chongbiao Huang · 3 shared papers, 2020–2022 · strength 0.35
  3. Xiuchao Wang · 3 shared papers, 2020–2022 · strength 0.35
  4. Song Gao · 3 shared papers, 2020–2022 · strength 0.35
  5. Shengyu Yang · 2 shared papers, 2020–2022 · strength 0.24
  6. Chuntao Gao · 2 shared papers, 2021–2022 · strength 0.24
  7. Wenrun Cai · 2 shared papers, 2021–2022 · strength 0.24
  8. Jing Liu · 2 shared papers, 2021–2022 · strength 0.24
  9. Jihui Hao · 2 shared papers, 2020–2021 · strength 0.22
  10. Ming Yu · 1 shared paper, 2020 · strength 0.16
  11. Zhe Liu · 1 shared paper, 2022 · strength 0.13
  12. Jihui Hao · 1 shared paper, 2022 · strength 0.13
  13. Jing Liu · 1 shared paper, 2020 · strength 0.11
  14. Xugang Sun · 1 shared paper, 2021 · strength 0.11
  15. Huizhi Sun · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.